Oncodesign and the Laboratory for Neurobiology and Gene Therapy at the KU Leuven enter into a research collaboration for advancing drug discovery efforts with Ipsen in Parkinson's disease
18/12/12
Communiqués de presse 2012 (anglais uniquement)
Oncodesign enters into a research collaboration and license agreement with Sanofi for the application of Oncodesign’s Nanocyclix® technology to Sanofi’s Kinase targets
13/09/12
Oncodesign and Ipsen enter into a research collaboration for the development of new therapeutic agents against the LRRK2 Parkinson's disease target
05/01/12